Characterization of endothelial factors involved in the vasodilatory effect of simvastatin in aorta and small mesenteric artery of the rat
- 1 November 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (6) , 1179-1187
- https://doi.org/10.1038/sj.bjp.0703668
Abstract
1. Vascular effects of the 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, simvastatin, were studied in conductance (aorta) and resistance vessels (branch II or III of superior mesenteric artery, SMA) of the rat (12 - 14 weeks old). 2. Simvastatin produced relaxation of both aorta and SMA, with and without functional endothelium. These responses were inhibited by the product of HMG-CoA reductase, mevalonate (1 mmol l(-1)). 3. In vessels with functional endothelium, the NO-synthase inhibitor, L-N(G)-nitroarginine (L-NOARG, 30 micromol l(-1)), inhibited simvastatin-induced relaxation. In the presence of L-NOARG, relaxation to simvastatin was lower in vessels with endothelium than in endothelium-denuded arteries without L-NOARG. 4. The cyclo-oxygenase inhibitor, indomethacin (10 micromol l(-1)), abolished endothelium-dependent component of the response to simvastatin in both arteries. The combination of L-NOARG plus indomethacin did not produce further inhibition. The T(p) receptor antagonist, GR 32191B (3 micromol l(-1)), did not affect relaxation in aorta but it reduced response to low concentrations of simvastatin in SMA. However, the inhibitory effect of L-NOARG was less marked in the presence of GR 32191B in aorta but not in SMA. 5. The endothelium-dependent relaxation to simvastatin was inhibited by the superoxide dismutase (SOD, 100 u ml(-1)) or by the tyrosine kinase inhibitor, genistein (30 micromol l(-1)) in the two arteries. 6. The present study shows that simvastatin produces relaxation of conductance and small arteries through mevalonate-sensitive pathway. The endothelium-dependent relaxation to simvastatin involves both NO and vasodilator eicosanoids by a mechanism sensitive to SOD, and to genistein. Also, the results highlighted participation in the aorta of endothelial vasoconstrictor eicosanoids acting on the T(p) receptor after blockage of NO synthase only.Keywords
This publication has 44 references indexed in Scilit:
- Role of tyrosine phosphorylation of phospholipase C γ1 in the signaling pathway of HMG‐CoA reductase inhibitor‐induced cell death of L6 myoblastsFEBS Letters, 1999
- An in Vitro Study of the Hydroxyl Radical Scavenging Property of Fluvastatin, an HMG-CoA Reductase Inhibitor.CHEMICAL & PHARMACEUTICAL BULLETIN, 1999
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Nitric oxide production and endothelium‐dependent vasorelaxation induced by wine polyphenols in rat aortaBritish Journal of Pharmacology, 1997
- Simvastatin Releases Ca2+ from a Thapsigargin-Sensitive Pool and Inhibits InsP3-Dependent Ca2+ Mobilization in Vascular Smooth Muscle CellsJournal of Cardiovascular Pharmacology, 1996
- Inhibition of Isoprenoid Biosynthesis and Arterial Smooth-Muscle Cell ProliferationJournal of Cardiovascular Pharmacology, 1995
- Tyrosine Kinase May Participate in Ca2+ Entry for Endothelial Nitric Oxide ProductionThe Japanese Journal of Pharmacology, 1995
- NG-Nitro-L-Arginine Contracts Vascular Smooth Muscle by an Endothelium-Independent MechanismJournal of Cardiovascular Pharmacology, 1994
- Effects of growth factors on cell cycle arrest in dolichyl phosphate-depleted culturesJournal of Cellular Physiology, 1993
- Regulation of the mevalonate pathwayNature, 1990